SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-010970
Filing Date
2018-08-06
Accepted
2018-08-06 06:11:14
Documents
41
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 357759
2 ex31-1.htm EX-31.1 11383
3 ex31-2.htm EX-31.2 11708
4 ex32-1.htm EX-32.1 6603
5 ex32-2.htm EX-32.2 6217
  Complete submission text file 0001493152-18-010970.txt   1522509

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE capd-20180630.xml EX-101.INS 154663
7 XBRL SCHEMA FILE capd-20180630.xsd EX-101.SCH 17573
8 XBRL CALCULATION FILE capd-20180630_cal.xml EX-101.CAL 29827
9 XBRL DEFINITION FILE capd-20180630_def.xml EX-101.DEF 51411
10 XBRL LABEL FILE capd-20180630_lab.xml EX-101.LAB 126325
11 XBRL PRESENTATION FILE capd-20180630_pre.xml EX-101.PRE 101009
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

IRS No.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26027 | Film No.: 18993406
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1